MedPage Today

Not All CTE Leads to Dementia, Large Study Shows

Brain donors with stage IV CTE pathology and no other progressive brain disease had four times the odds of a dementia ...
ascopubs.org

Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study)

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
MedPage Today

Gabriel Hortobagyi on a New Postneoadjuvant Prognostic Staging System for Breast Cancer

A novel prognostic staging system predicted survival for patients with breast cancer after neoadjuvant chemotherapy (NACT), addressing an unmet need, researchers reported. One of the benefits of ...
Morningstar

ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY ...

Highest reported pathologic complete response rate seen in a phase 3 registrational trial for HER2 positive early breast cancer with favorable safety profile versus standard treatment DESTINY-Breast11 ...
Seeking Alpha

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early ...

Highest reported pathologic complete response rate seen in a Phase III registrational trial for HER2-positive early breast cancer with favorable safety profile vs. standard treatment DESTINY-Breast11 ...